X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1504) 1504
Publication (79) 79
Book Review (4) 4
Conference Proceeding (4) 4
Book Chapter (3) 3
Dissertation (3) 3
Government Document (2) 2
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (940) 940
cystamine - pharmacology (627) 627
cystamine (528) 528
rats (419) 419
male (400) 400
mice (368) 368
humans (305) 305
female (218) 218
index medicus (204) 204
cysteamine (178) 178
cystamine - analogs & derivatives (168) 168
biochemistry & molecular biology (164) 164
cystamine - therapeutic use (140) 140
time factors (125) 125
cystamine - chemistry (118) 118
radiation effects (107) 107
radiation-protective agents - pharmacology (106) 106
kinetics (103) 103
in vitro techniques (100) 100
pharmacology & pharmacy (98) 98
oxidation-reduction (97) 97
cysteamine - pharmacology (90) 90
cystamine - metabolism (83) 83
dose-response relationship, drug (82) 82
research (82) 82
cystamine - administration & dosage (78) 78
transglutaminases - metabolism (78) 78
transglutaminases - antagonists & inhibitors (73) 73
enzyme inhibitors - pharmacology (72) 72
radiation-protective agents (71) 71
rabbits (68) 68
radiation injuries, experimental - prevention & control (66) 66
tissue transglutaminase (66) 66
rats, inbred strains (65) 65
radiation protection (64) 64
glutathione (63) 63
adrenergic alpha-antagonists - pharmacology (62) 62
hydrogen-ion concentration (58) 58
amines (57) 57
cysteine (57) 57
cells, cultured (56) 56
liver - metabolism (55) 55
analysis (54) 54
dogs (54) 54
proteins (52) 52
cell biology (50) 50
mercaptoethylamines - pharmacology (50) 50
gamma rays (49) 49
radiation-protective agents - therapeutic use (49) 49
biophysics (48) 48
organic sulfur compounds (48) 48
apoptosis (47) 47
cells (47) 47
chemistry (47) 47
neurosciences (47) 47
inhibition (46) 46
rats, sprague-dawley (45) 45
cell line (44) 44
brain (43) 43
liver - drug effects (43) 43
pharmacology (43) 43
cross-linking (42) 42
metabolism (42) 42
beta-aminoethyl isothiourea - pharmacology (41) 41
mice, inbred c57bl (41) 41
transglutaminase (40) 40
sulfhydryl compounds - pharmacology (39) 39
enzymes (38) 38
oxidative stress (38) 38
oxygen (37) 37
radiation dosage (37) 37
adult (36) 36
cell line, tumor (36) 36
disease models, animal (36) 36
5-methoxytryptamine - pharmacology (35) 35
disulfides (35) 35
dna (35) 35
huntingtons-disease (35) 35
liver - enzymology (35) 35
expression (33) 33
cattle (32) 32
cystamine - toxicity (32) 32
glutathione - metabolism (32) 32
gtp-binding proteins - metabolism (32) 32
model (32) 32
radiation-protective agents - administration & dosage (32) 32
serotonin - pharmacology (32) 32
chemical phenomena (31) 31
chemistry, multidisciplinary (31) 31
glutathione - pharmacology (31) 31
nanoparticles (31) 31
neurodegenerative diseases (31) 31
injections, intraperitoneal (30) 30
article (29) 29
cysteamine - metabolism (29) 29
drug synergism (29) 29
gtp-binding proteins - antagonists & inhibitors (29) 29
in-vitro (29) 29
irradiation (29) 29
toxicity (29) 29
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1078) 1078
Russian (276) 276
French (85) 85
German (20) 20
Czech (18) 18
Italian (16) 16
Chinese (6) 6
Korean (4) 4
Japanese (2) 2
Polish (2) 2
Romanian (2) 2
Serbian (1) 1
Spanish (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 02/2012, Volume 62, Issue 2, pp. 997 - 1003
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2002, Volume 8, Issue 2, pp. 143 - 149
An expanded polyglutamine domain in huntingtin underlies the pathogenic events in Huntington disease (HD), characterized by chorea, dementia and severe weight... 
cystamine
Journal Article
Journal Article
Biomaterials, ISSN 0142-9612, 09/2018, Volume 178, pp. 1 - 10
Journal Article
The Journal of Organic Chemistry, ISSN 0022-3263, 10/2010, Volume 75, Issue 19, pp. 6696 - 6699
Journal Article
Genetics, ISSN 0016-6731, 05/2016, Volume 203, Issue 1, pp. 599 - 609
Journal Article
Biomaterials, ISSN 0142-9612, 2010, Volume 32, Issue 5, pp. 1253 - 1263
Journal Article
Progress in Neuropsychopharmacology & Biological Psychiatry, ISSN 0278-5846, 03/2011, Volume 35, Issue 2, pp. 380 - 389
Neurodegenerative disorders are a subset of disabling pathologies characterized, in part, by a progressive and specific loss of certain brain cell populations.... 
Neurorescue | Neuroprotection | Parkinson's disease | Neurorestoration | Huntington's disease | OXIDATIVE STRESS | PSYCHIATRY | SYNUCLEIN ACTIVATES MICROGLIA | NEUROTROPHIC FACTOR | SUBSTANTIA-NIGRA | NEUROSCIENCES | CLINICAL NEUROLOGY | NIGROSTRIATAL DOPAMINERGIC SYSTEM | TUMOR-NECROSIS-FACTOR | A VIRUS-REPLICATION | TRANSGLUTAMINASE INHIBITOR CYSTAMINE | PHARMACOLOGY & PHARMACY | IDIOPATHIC PARKINSONS-DISEASE | HUNTINGTONS-DISEASE | Cysteamine - pharmacology | Neuroprotective Agents - therapeutic use | Cysteamine - chemistry | Humans | Enzyme Inhibitors - pharmacology | Radiation-Protective Agents - chemistry | Mice, Transgenic | Parkinson Disease - drug therapy | Molecular Targeted Therapy | Neurodegenerative Diseases - drug therapy | Parkinson Disease - physiopathology | Enzyme Inhibitors - therapeutic use | Cystamine - therapeutic use | Animals | Neurodegenerative Diseases - physiopathology | Cystamine - chemistry | Cysteamine - therapeutic use | Enzyme Inhibitors - chemistry | Radiation-Protective Agents - pharmacology | Cystamine - pharmacology | Mice | Huntington Disease - drug therapy | Huntington Disease - physiopathology | Disease Models, Animal | Ubiquitin | COX-2 inhibitors | Care and treatment | Glutathione transferase | Analysis | Heat shock proteins | Nervous system | Degeneration | Health aspects
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 12/2014, Volume 45, pp. 491 - 496
Construction and biofunctional evaluation of a novel vascular graft with catalytic generation of nitric oxide were described in this paper. Poly α-lysine and... 
Selenocystamine | Catalytic generation | Nitric oxide | Anti-thrombosis | Vascular graft | POLYMERS | BIOCOMPATIBILITY | COMPLEX | MATERIALS SCIENCE, BIOMATERIALS | DECOMPOSITION | SENSORS | ENDOTHELIALIZATION | ADHESION | S-NITROSOTHIOLS | SURFACE | IMPROVING BLOOD-COMPATIBILITY | Biocompatible Materials - chemistry | Male | Polylysine - chemistry | Organoselenium Compounds - chemistry | Organoselenium Compounds - pharmacology | Cystamine - therapeutic use | Cystamine - analogs & derivatives | Cystamine - chemistry | Surface Properties | Cystamine - pharmacology | S-Nitrosoglutathione | Thrombosis - prevention & control | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Organoselenium Compounds - therapeutic use | Cells, Cultured | Prostheses and Implants | Rats | Biocompatible Materials - pharmacology | Rats, Sprague-Dawley | Cell Movement - drug effects | Polyesters - chemistry | Polyglutamic Acid - chemistry | Animals | Cytoskeleton - metabolism | Biocompatible Materials - therapeutic use | Cell Proliferation - drug effects | Mice | Nitric Oxide - metabolism | 3T3 Cells | Cytoskeleton - drug effects | Transplantation of organs, tissues, etc | Analysis | Self assembly | Construction | Catalysts | Electrospinning | Activation | Catalysis | Grafting
Journal Article
Autophagy, ISSN 1554-8627, 11/2012, Volume 8, Issue 11, pp. 1657 - 1672
Channel activators (potentiators) of cystic fibrosis (CF) transmembrane conductance regulator (CFTR), can be used for the treatment of the small subset of CF... 
cystamine | CFTR potentiators | autophagy | cystic fibrosis | therapy | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Therapy | Cystic fibrosis | Autophagy | Cystamine | GAMMA DOWN-REGULATION | OXIDATIVE STRESS | F508DEL-CFTR | PLASMA-MEMBRANE | INTESTINAL EPITHELIAL-CELLS | CELL BIOLOGY | PROTEIN-QUALITY CONTROL | MUTATION | TISSUE TRANSGLUTAMINASE | LUNG INFLAMMATION | CFTR | Inflammation - pathology | Epithelial Cells - metabolism | Sequestosome-1 Protein | Epithelial Cells - drug effects | Humans | Cystic Fibrosis - pathology | Male | Nasal Mucosa - pathology | Molecular Targeted Therapy | Autophagy - drug effects | Salicylates - pharmacology | Cystamine - therapeutic use | Organometallic Compounds - therapeutic use | Cystamine - pharmacology | Female | Cell Membrane - metabolism | Membrane Proteins - metabolism | Child | Cell Membrane - drug effects | Nasal Mucosa - drug effects | Beclin-1 | Epithelium - drug effects | Epithelium - pathology | Lung - pathology | Nasal Polyps - pathology | Epithelium - metabolism | Heat-Shock Proteins - metabolism | Epithelial Cells - pathology | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Antioxidants - pharmacology | Salicylates - therapeutic use | Apoptosis Regulatory Proteins - metabolism | Animals | Lung - drug effects | Adolescent | Genistein - pharmacology | Lipopolysaccharides - pharmacology | Mice | Adaptor Proteins, Signal Transducing - metabolism | Cystic Fibrosis - drug therapy | Organometallic Compounds - pharmacology | Translational Research Paper
Journal Article